Origin BioMed Selected Top Canadian Business at Red Herring Awards

    Halifax-based consumer health products recognized for unique technology

    HALIFAX, Nova Scotia, Sept. 22 /CNW/ -- Origin BioMed Inc., a
privately-held Canadian consumer health products company, was honoured at the
second annual Red Herring Top 50 Canada Awards held in Mont-Tremblant, Quebec,
on September 16.  Red Herring, the leading California technology publication,
named Origin BioMed Inc. the most innovative and promising technology company
in Canada in its category.
    The Red Herring editorial team used an intensely competitive process to
select the most innovative companies. The nominees were rigidly evaluated on
both quantitative and qualitative criteria, such as financial performance,
technology innovation, quality of management, execution of strategy, and
integration into their ecosystem.
    "Since its inception, Origin's mission has been to leverage cutting edge
technology to bring scientifically proven natural products to professional
care givers and consumers. We strive to increase over-the-counter treatment
options for nerve pain, and Red Herring's recognition demonstrates that our
model drives novelty and improvement within our industry," said Robert
Cervelli, President and CEO, Origin BioMed. "It was a real honour to accept
this award on behalf of the entire team at Origin, who relentlessly focus on
moving forward innovations," he added.
    Origin BioMed's leading drug product, Neuragen(R), is the first non-
prescription topical treatment for rapid relief of diabetic and post-shingles
nerve pain. Neuragen(R) is available in leading pharmacies in Canada and was
recently launched in the United States.
    About Origin BioMed Inc.
    Origin BioMed, Inc. is a privately-held Canadian consumer health products
company with business operations throughout the U.S. and Canada. Headquartered
in Halifax, Nova Scotia, Origin BioMed Inc. manufactures health products with
the highest quality active ingredients, at therapeutic levels, with evidence
of scientific or clinical efficacy since 2001.  Its leading drug product,
Neuragen(R), helps relieve pain caused by diabetic nerve damage. For more
information, please visit: www.originbiomed.com or www.neuragen.com.

For further information:

For further information: Robert Silverstein, Senior Sales and Marketing
Director, +1-902-444-8696, silverstein@originbiomed.com Web Site:
http://www.originbiomed.com                 http://www.neuragen.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890